TABLE 2:

PCT rCBF values for the ischemic area

GroupSampling Interval
0.5 second1 second*2 seconds3 seconds4 seconds5 seconds6 seconds
1 (30 mL)
 Mean ± SD10.1 ± 4.711.7 ± 6.012.3 ± 6.124.4 ± 12.154.2 ± 27.4102.2 ± 50.2238.3 ± 188.0
 Range−9.2% to +17.3%NA−10.0% to +18.4%+18.1% to +126.3%+151.1% to +402.4%+513.7% to +991.1%+1183.9% to +2561.1%
P value.450NA.803.004<.001<.001<.001
2 (40 mL)
 Mean ± SD11.4 ± 5.112.9 ± 4.912.0 ± 5.113.8 ± 6.347.1 ± 23.385.9 ± 35.9194.8 ± 137.9
 Range−10.0% to +16.2%NA−9.4% to +17.4%−8.9% to +18.2%+115.1% to +319.9%+392.6% to +718.7%+946.0% to +1945.8%
P value.958NA.653.683<.001<.001<.001
3 (50 mL)
 Mean ± SD9.8 ± 4.911.3 ± 4.59.6 ± 4.111.4 ± 5.325.6 ± 12.247.1 ± 20.760.3 ± 31.8
 Range−10.6% to +18.1%NA−10.0% to +18.8%−9.5% to +19.8%+55.8% to +171.1%+251.6% to +439.4%+380.4% to +795.1%
P value.494NA.393.939.001<.001<.001
4 (60 mL)
 Mean ± SD9.6 ± 4.49.7 ± 4.49.3 ± 4.09.2 ± 4.310.6 ± 5.723.4 ± 12.029.6 ± 19.0
 Range−9.7% to +19.8%NA−9.6% to +19.2%−10.0% to +17.3%−8.9% to +18.6%+118.9% to +286.7%+136.9% to +324.7%
P value.970NA.777.776.216.001.001
  • Note.—No significant difference (P = .166, Kruskal-Wallis) was identified among the four groups for rCBF values obtained with an interval of 1 second. Range indicates the overestimation or underestimation compared with the reference. Values in boldface indicate the temporal sampling interval thresholds beyond which rCBF values were significantly overestimated.

  • * Reference for Wilcoxon (Mann-Whitney) tests performed in each group. NA indicates not applicable.